| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,380 | $30 | $268K |
| J3262 | Injection, tocilizumab, 1 mg | 33,800 | $10 | $169K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 16,130 | $10 | $161.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,270 | $100 | $129.6K |
| J0897 | Injection, denosumab, 1 mg | 6,300 | $20 | $113.4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,530 | $30 | $65.7K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 16,000 | $1 | $64K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 290 | $110 | $31.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 160 | $150 | $24.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 100 | $140 | $14.5K |